×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ANIP – ani pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ANIP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/31
08:23 pm
anip
ANI Pharmaceuticals 2026 Watchlist: Gout Sales Force and Rare Disease [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals 2026 Watchlist: Gout Sales Force and Rare Disease [Yahoo! Finance]
3/27
09:03 pm
anip
ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025 [Yahoo! Finance]
Medium
Report
ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025 [Yahoo! Finance]
3/24
09:14 pm
anip
3 Reasons ANIP is Risky and 1 Stock to Buy Instead [Yahoo! Finance]
Low
Report
3 Reasons ANIP is Risky and 1 Stock to Buy Instead [Yahoo! Finance]
3/21
08:18 pm
anip
ANI Pharmaceuticals Expands Ophthalmology Reach As Valuation Signals Upside Potential [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals Expands Ophthalmology Reach As Valuation Signals Upside Potential [Yahoo! Finance]
3/13
03:26 am
anip
Sizing Up ANI Pharmaceuticals (ANIP) After Recent Share Price Pullback [Yahoo! Finance]
Low
Report
Sizing Up ANI Pharmaceuticals (ANIP) After Recent Share Price Pullback [Yahoo! Finance]
3/11
05:27 pm
anip
ANI Pharmaceuticals, Inc. (ANIP) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Medium
Report
ANI Pharmaceuticals, Inc. (ANIP) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/11
01:31 am
anip
ANI Pharmaceuticals Targets $1.1B 2026 Revenue as Cortrophin Sales Surge, Gout Launch Set for Midyear [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals Targets $1.1B 2026 Revenue as Cortrophin Sales Surge, Gout Launch Set for Midyear [Yahoo! Finance]
3/9
09:54 am
anip
Insider Trades And Rare Disease Growth Shape ANI Pharmaceuticals Valuation [Yahoo! Finance]
Low
Report
Insider Trades And Rare Disease Growth Shape ANI Pharmaceuticals Valuation [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
2/27/2026
06:50 am
anip
ani pharmaceuticals, inc.
BEAT
Report
-11.0%
ani pharmaceuticals, inc.
11/7/2025
06:50 am
anip
ani pharmaceuticals, inc.
BEAT
Report
-1.7%
ani pharmaceuticals, inc.
5/9/2025
06:50 am
anip
ani pharmaceuticals, inc.
BEAT
Report
-10.5%
ani pharmaceuticals, inc.
Date
Time
Symbol
Headline
Impact
3/26
03:46 pm
anip
Form SCHEDULE 13G/A ANI PHARMACEUTICALS INC Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A ANI PHARMACEUTICALS INC Filed by: VANGUARD GROUP INC
3/13
05:29 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Mar 11 Filed by: Rowland Thomas Andrew
Low
Report
Form 4 ANI PHARMACEUTICALS INC For: Mar 11 Filed by: Rowland Thomas Andrew
3/13
05:29 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Mar 13 Filed by: Cook Meredith
Low
Report
Form 4 ANI PHARMACEUTICALS INC For: Mar 13 Filed by: Cook Meredith
3/13
05:29 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Mar 13 Filed by: Mutz Christopher
Low
Report
Form 4 ANI PHARMACEUTICALS INC For: Mar 13 Filed by: Mutz Christopher
3/10
04:10 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Mar 06 Filed by: Mutz Christopher
Low
Report
Form 4 ANI PHARMACEUTICALS INC For: Mar 06 Filed by: Mutz Christopher
3/10
04:09 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Mar 07 Filed by: Lalwani Nikhil
Low
Report
Form 4 ANI PHARMACEUTICALS INC For: Mar 07 Filed by: Lalwani Nikhil
3/10
04:07 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Mar 07 Filed by: Gutwerg Ori
Low
Report
Form 4 ANI PHARMACEUTICALS INC For: Mar 07 Filed by: Gutwerg Ori
3/10
04:06 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Mar 06 Filed by: Davis Krista
Low
Report
Form 4 ANI PHARMACEUTICALS INC For: Mar 06 Filed by: Davis Krista
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/24
ANI Pharmaceuticals Announces the Filing of a Prior Approval Supplement for Purified Cortrophin® Gel 80 U/mL
18.7%
6/18 ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc. 10.0%
4/8 Form 4 ANI PHARMACEUTICALS INC For: Apr 06 Filed by: Schrepfer Robert W 8.0%
4/13 ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL 6.1%
9/12 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.6%
9/12 ANI Pharmaceuticals Inc (NASDAQ: ANIP) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock. 4.1%
1/9 ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd. 3.5%
6/28 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.4%
5/9 Q1/2019 3/31/2019 EPS 1.300 ZacksConsensus 1.030 ActVsEst 0.270 - Beat 3.1%
10/22 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.0%
6/18 ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc. 10.0%
4/8 Form 4 ANI PHARMACEUTICALS INC For: Apr 06 Filed by: Schrepfer Robert W 8.0%
4/13 ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL 6.1%
9/12 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.6%
9/12 ANI Pharmaceuticals Inc (NASDAQ: ANIP) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock. 4.1%
1/9 ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd. 3.5%
6/28 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.4%
5/9 Q1/2019 3/31/2019 EPS 1.300 ZacksConsensus 1.030 ActVsEst 0.270 - Beat 3.1%
10/22 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.0%
TOP News Decliners
11/6
Q3/2019 9/30/2019 EPS 1.230 ZacksConsensus 1.320 ActVsEst (0.090) - Miss
-23.7%
2/27 Q4/2019 12/31/2019 EPS 1.080 ZacksConsensus 1.020 ActVsEst 0.060 - Beat -18.7%
8/7 Q2/2019 6/30/2019 EPS 1.440 ZacksConsensus 1.180 ActVsEst 0.260 - Beat -15.1%
4/14 ANI Announces Upcoming Departure of CEO -9.0%
3/2 ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules -7.8%
3/4 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -7.3%
3/7 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.4%
3/31 Form 4 ANI PHARMACEUTICALS INC For: Mar 28 Filed by: PRZYBYL ARTHUR -6.3%
4/14 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -6.0%
1/7 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -5.1%
2/27 Q4/2019 12/31/2019 EPS 1.080 ZacksConsensus 1.020 ActVsEst 0.060 - Beat -18.7%
8/7 Q2/2019 6/30/2019 EPS 1.440 ZacksConsensus 1.180 ActVsEst 0.260 - Beat -15.1%
4/14 ANI Announces Upcoming Departure of CEO -9.0%
3/2 ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules -7.8%
3/4 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -7.3%
3/7 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.4%
3/31 Form 4 ANI PHARMACEUTICALS INC For: Mar 28 Filed by: PRZYBYL ARTHUR -6.3%
4/14 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -6.0%
1/7 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -5.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: